IRON
Disc Medicine, Inc.NASDAQHealthcare$65.18+0.62%ClosedMarket Cap: $2.49B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.14
P/S
0.00
EV/EBITDA
-11.70
DCF Value
$2.31
FCF Yield
-7.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-32.8%
ROA
-26.3%
ROIC
-30.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-67.0M | $-60.5M | $-1.64 | — |
| FY 2025 | $0.00 | -Infinity% | $-236.0M | $-212.2M | $-6.01 | — |
| Q3 2025 | $0.00 | -Infinity% | $-67.7M | $-62.3M | $-1.77 | — |
| Q2 2025 | $0.00 | NaN% | $-61.4M | $-55.2M | $-1.58 | — |
| Q1 2025 | $0.00 | NaN% | $-39.9M | $-34.1M | $-1.02 | — |
| Q4 2024 | $0.00 | -Infinity% | $-34.5M | $-29.5M | $-0.98 | — |
| FY 2024 | $0.00 | NaN% | $-129.7M | $-109.4M | $-3.96 | — |
| Q3 2024 | $0.00 | NaN% | $-32.9M | $-26.6M | $-0.89 | — |
| Q2 2024 | $0.00 | NaN% | $-30.9M | $-26.4M | $-1.03 | — |
| Q1 2024 | $0.00 | NaN% | $-31.5M | $-26.9M | $-1.09 | — |
| Q4 2023 | $0.00 | NaN% | $-29.7M | $-23.6M | $-1.00 | — |
| FY 2023 | $0.00 | NaN% | $-91.1M | $-76.4M | $-3.42 | — |